Clinical trial
Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly…
NCT00147875 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00147875 |
|---|---|
| Title | Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma |
| Official title | PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma |
| Lead sponsor | University of Cologne, Other |
| Collaborators | German Hodgkin's Lymphoma Study Group Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Disease |
| Intervention type | Drug |
| Interventions | Prednisone, Vinblastine, Doxorubicin (Adriamycin), Gemcitabine |
| Enrollment | 60 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Sep 7, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: